Prospective registry for geniculate arterial embolisation as treatment for osteoarthritis and neovascularity.
- Conditions
- Knee osteoarthritisMusculoskeletal - Osteoarthritis
- Registration Number
- ACTRN12622000621718
- Lead Sponsor
- I-MED Radiology Network
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion criteria for group A (patients with moderate-to-severe chronic pain following TKA):
-Age 40 yrs or older who are willing and able to provide informed consent
-Experiencing ongoing moderate to severe pain for at least 6 months after total knee arthroplasty
- and having failed conservative medical treatment for at least 6 months (e.g. physiotherapy/anti-inflammatory/analgesia/masso-kinesiotherapy, etc.)
Inclusion criteria for group B (patients with moderate-to-severe KOA):
-Age 40 yrs or older who are willing and able to provide informed consent
-Presence of moderate to severe knee OA as stipulated by referring orthopedic surgeon
-Presence of knee pain for at least 6 months, resistant to conservative treatments (e.g. physiotherapy, analgesia, exercise, weight loss, intra-articular injections, etc.)
-Non-surgical candidates: ineligible/refused total knee arthroplasty (TKA)
Exclusion criteria for group A (patients with moderate-to-severe chronic pain following TKA):
-Rheumatoid, infectious arthritis, osteonecrosis, or advanced atherosclerosis
-Malignancy
-Renal impairment (eGFR <45)
-A bleeding diathesis
-Irreversible coagulopathy
-Re-operation
-Allergic to contrast media
Exclusion criteria for group B (patients with moderate-to-severe KOA):
-Rheumatoid, infectious arthritis, osteonecrosis, or advanced atherosclerosis
-Malignancy
-Renal impairment (eGFR <45)
-A bleeding diathesis
-Irreversible coagulopathy
-Allergic to contrast media
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method